1. Home
  2. GRI vs CNEY Comparison

GRI vs CNEY Comparison

Compare GRI & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

N/A

Current Price

$1.75

Market Cap

3.0M

Sector

Health Care

ML Signal

N/A

Logo CN Energy Group Inc.

CNEY

CN Energy Group Inc.

N/A

Current Price

$0.44

Market Cap

2.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GRI
CNEY
Founded
2018
2009
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
GRI
CNEY
Price
$1.75
$0.44
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $18.50
N/A
AVG Volume (30 Days)
38.3K
★ 83.3K
Earning Date
11-24-2026
02-17-2027
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.18
$0.31
52 Week High
$64.12
$2.63

Technical Indicators

Market Signals
Indicator
GRI
CNEY
Relative Strength Index (RSI) 52.86 47.00
Support Level $1.71 $0.36
Resistance Level $2.66 $0.60
Average True Range (ATR) 0.17 0.06
MACD 0.04 0.00
Stochastic Oscillator 62.01 47.93

Price Performance

Historical Comparison
GRI
CNEY

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: